Cellectar Biosciences press release (NASDAQ:CLRB): Q1 GAAP EPS of -$0.74 misses by $0.18. As of March 31, 2024, the company had cash and cash equivalents of $40.0 million, compared to $9.6 million as...
Source LinkCellectar Biosciences press release (NASDAQ:CLRB): Q1 GAAP EPS of -$0.74 misses by $0.18. As of March 31, 2024, the company had cash and cash equivalents of $40.0 million, compared to $9.6 million as...
Source Link
Comments